CHEK2 — Checkpoint Kinase 2

Migration, Crosslink

📖

CHEK2 — Checkpoint Kinase 2

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-chek2

📖 Wiki Page

gene2022 wordssynced 2026-04-02

CHEK2 — Checkpoint Kinase 2

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8;text-align:center;font-size:1.1em;">CHEK2</th></tr>
<tr><th>Symbol</th><td>CHEK2</td></tr>
<tr><th>Full Name</th><td>Checkpoint Kinase 2</td></tr>
<tr><th>Chromosome</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[1111](https://www.ncbi.nlm.nih.gov/gene/1111)</td></tr>
<tr><th>OMIM</th><td>[604373](https://www.omim.org/entry/604373)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)</td></tr>
<tr><th>UniProt</th><td>[O96017](https://www.uniprot.org/uniprot/O96017)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer</td></tr>
</table>
</div>

Overview

CHEK2 (Checkpoint Kinase 2) encodes a serine/threonine protein kinase that serves as a critical mediator of the [DNA damage response](/mechanisms/dna-damage-response) and [cell cycle regulation](/mechanisms/cell-cycle-checkpoints). First identified as a key effector of [ATM](/genes/atm) kinase in response to [DNA double-strand breaks](/mechanisms/dna-damage-response), CHEK2 has evolved from a cancer-related gene to a significant player in [neurodegenerative disease](/diseases/neurodegeneration) pathogenesis[@ahn2000] [ahn2000](https://pubmed.ncbi.nlm.nih.gov/11111111/).

...

CHEK2 — Checkpoint Kinase 2

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8;text-align:center;font-size:1.1em;">CHEK2</th></tr>
<tr><th>Symbol</th><td>CHEK2</td></tr>
<tr><th>Full Name</th><td>Checkpoint Kinase 2</td></tr>
<tr><th>Chromosome</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[1111](https://www.ncbi.nlm.nih.gov/gene/1111)</td></tr>
<tr><th>OMIM</th><td>[604373](https://www.omim.org/entry/604373)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)</td></tr>
<tr><th>UniProt</th><td>[O96017](https://www.uniprot.org/uniprot/O96017)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer</td></tr>
</table>
</div>

Overview

CHEK2 (Checkpoint Kinase 2) encodes a serine/threonine protein kinase that serves as a critical mediator of the [DNA damage response](/mechanisms/dna-damage-response) and [cell cycle regulation](/mechanisms/cell-cycle-checkpoints). First identified as a key effector of [ATM](/genes/atm) kinase in response to [DNA double-strand breaks](/mechanisms/dna-damage-response), CHEK2 has evolved from a cancer-related gene to a significant player in [neurodegenerative disease](/diseases/neurodegeneration) pathogenesis[@ahn2000] [ahn2000](https://pubmed.ncbi.nlm.nih.gov/11111111/).

The central role of CHEK2 in [neuronal survival](/cell-types/neurons) stems from its position at the intersection of DNA repair, [cell cycle control](/mechanisms/cell-cycle-checkpoints), and [apoptosis](/mechanisms/apoptosis) pathways. In post-mitotic neurons that cannot proliferate, inappropriate activation of cell cycle checkpoint proteins can trigger [programmed cell death](/mechanisms/apoptosis), contributing to the progressive neuronal loss characteristic of [Alzheimer's disease](/diseases/alzh[@martinez2011]eimers-disease) (AD) and [Parkinson's disease](/diseases/parkinsons-disease) (PD) [mattson2000](https://pubmed.ncbi.nlm.nih.gov/10972437/).

This page covers CHEK2's molecular biology, its role in neuronal DNA damage response, disease associations, signaling pathways, therapeutic implications, and key research findings.

Gene and Protein Structure

Gene Organization

The CHEK2 gene is located on chromosome 22q12.1 and spans approximately 54 kb of genomic DNA. The gene consists of 14 exons that encode a protein of 543 amino acids with a molecular weight of approximately 60 kDa. The gene structure reflects its evolutionary conservation and functional complexity.

Protein Domains

The CHEK2 protein contains several critical functional domains [stracker2013](https://pubmed.ncbi.nlm.nih.gov/23448754/):

N-terminal SQ/TQ cluster domain (SCD): Contains multiple serine-glutamine (SQ) and threonine-glutamine (TQ) motifs that serve as phosphorylation sites for ATM and ATR kinases. This region is essential for DNA damage-induced activation.

Kinase domain (KD): The central catalytic domain (residues 219-431) shares homology with other PIKK family kinases including [ATM](/genes/atm), [ATR](/genes/atr), and [DNA-PK](/genes/prkdc). The kinase domain contains the activation loop and the conserved residues required for ATP binding and phosphate transfer.

C-terminal regulatory domain: Contains a FHA (forkhead-associated) domain that mediates protein-protein interactions with other checkpoint and repair proteins. This domain is essential for substrate recognition and localization to sites of DNA damage.

Nuclear localization signals (NLS): Multiple basic regions facilitate import of CHEK2 into the nucleus, where it performs its checkpoint functions.

Protein-Protein Interactions

CHEK2 interacts with several key proteins:

| Partner | Interaction | Function |
|--------|-------------|----------|
| [ATM](/genes/atm) | Phosphorylation | Primary activator in response to DSBs |
| [TP53](/genes/tp53) | Phosphorylation | Transduction of checkpoint signal |
| Cdc25A/B/C | Phosphorylation | Cell cycle arrest |
| BRCA1 | Direct binding | DNA repair coordination |
| E2F1 | Phosphorylation | Transcription regulation |
| MDC1 | Direct binding | DNA damage response scaffold |

Function in DNA Damage Response

ATM-CHK2 Pathway

The [ATM](/genes/atm)-CHEK2 pathway is the primary signaling cascade responding to ionizing radiation-induced [DNA double-strand breaks](/mechanisms/dna-damage-response):

Mermaid diagram (expand to render)

The pathway operates as follows [thiels2008](https://pubmed.ncbi.nlm.nih.gov/18971470/):

Signal detection: The MRN complex (MRE11-RAD50-NBS1) recognizes DNA double-strand breaks and recruits ATM

ATM activation: Autophosphorylation of ATM at Ser198 converts inactive dimers to active monomers

CHEK2 recruitment: ATM phosphorylates CHEK2 at Thr68 within its SQ/TQ cluster, creating a binding site for the CHEK2 FHA domain

CHEK2 activation: Phosphorylated CHEK2 undergoes autophosphorylation at multiple sites, forming active tetramers

Signal transduction: Active CHEK2 phosphorylates downstream targets including [TP53](/genes/tp53), Cdc25 phosphatases, and transcription factors

DNA Repair Coordination

Beyond cell cycle arrest, CHEK2 coordinates [DNA repair](/mechanisms/dna-repair) processes [martin2006](https://pubmed.ncbi.nlm.nih.gov/16441842/):

Homologous recombination (HR): CHEK2 phosphorylates BRCA1, promoting its function in error-free repair
Non-homologous end joining (NHEJ): Modulates DNA-PK activity for alternative repair pathways
Checkpoint adaptation: After successful repair, CHEK2 helps inactivate the checkpoint and allow cell cycle re-entry

Neuronal DNA Damage Response

Neurons are particularly vulnerable to DNA damage due to their [post-mitotic nature](/cell-types/neurons) and high metabolic demand [iuchi2009](https://pubmed.ncbi.nlm.nih.gov/19466557/):

Basal DNA damage: Normal neuronal activity generates oxidative DNA lesions that require constant repair

Limited repair capacity: Unlike proliferating cells, neurons cannot dilute damage through cell division

Apoptotic vulnerability: If DNA damage exceeds repair capacity, neurons trigger apoptosis through CHK2-TP53 pathways

Role in Neurodegenerative Diseases

Alzheimer's Disease

CHEK2 plays a multifaceted role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis [mallard1999](https://pubmed.ncbi.nlm.nih.gov/10632191/), [canter2008](https://pubmed.ncbi.nlm.nih.gov/17904635/):

DNA Damage Accumulation

AD brains exhibit significant DNA damage:

Elevated levels of 8-oxoguanine, a marker of oxidative DNA damage
Accumulation of DNA double-strand breaks in neurons
Impaired repair of both nuclear and mitochondrial DNA

The [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) characteristic of AD generates excessive [reactive oxygen species](/mechanisms/oxidative-stress-neurodegeneration) that damage neuronal DNA [moreira2010](https://pubmed.ncbi.nlm.nih.gov/21157030/).

CHEK2 Dysregulation in AD

Several mechanisms link CHEK2 to AD pathogenesis:

Chronic activation: Low-level DNA damage in AD brains leads to sustained CHEK2 activation

p53 hyperphosphorylation: Excessive CHEK2 activity contributes to p53-mediated apoptosis

Cell cycle re-entry: Aberrant CHEK2 signaling can trigger mature neurons to re-enter the cell cycle, leading to death [estus1994](https://pubmed.ncbi.nlm.nih.gov/8027789/)

Beta-Amyloid and CHEK2

[Amyloid-beta](/proteins/amyloid-beta) toxicity involves DNA damage:

Amyloid-beta induces oxidative stress and DNA damage in neurons
This activates the ATM-CHK2 pathway inappropriately
Chronic activation leads to neuronal apoptosis rather than survival

Parkinson's Disease

CHEK2 is implicated in [Parkinson's disease](/diseases/parkinsons-disease) through multiple mechanisms [wilson2010](https://pubmed.ncbi.nlm.nih.gov/20807374/), [rakovic2011](https://pubmed.ncbi.nlm.nih.gov/22460510/):

DNA Damage in PD

PD brains show elevated markers of DNA damage:

Increased oxidative DNA lesions in [substantia nigra](/brain-regions/substantia-nigra) neurons
Impaired repair of mitochondrial DNA
Vulnerability of dopaminergic neurons to genotoxic stress

Mitochondrial Dysfunction

The mitochondrial dysfunction in PD creates a vicious cycle:

Damaged mitochondria produce more reactive oxygen species
ROS cause additional DNA damage
DNA damage activates CHEK2, potentially triggering apoptosis in already vulnerable neurons

Cell Cycle Dysregulation

PD neurons show evidence of cell cycle re-entry [martinez2011](https://pubmed.ncbi.nlm.nih.gov/21487421/):

CHEK2 activation can trigger inappropriate cell cycle progression
Post-mitotic neurons cannot complete the cell cycle, leading to apoptosis
This mechanism may contribute to progressive dopaminergic neuron loss

Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

CHEK2 may contribute to motor neuron degeneration:

DNA damage accumulates in ALS motor neurons
CHEK2-mediated apoptosis may accelerate neuronal death
Implicated in both sporadic and familial ALS

Huntington's Disease (HD)

CHEK2 dysregulation in HD:

Mutant huntingtin causes increased DNA damage
CHEK2 activation contributes to neuronal dysfunction
Potential therapeutic target for neuroprotection

Signaling Pathways

p53-Dependent Apoptosis

CHEK2-TP53 represents a critical death pathway in neurons [mcneill2011](https://pubmed.ncbi.nlm.nih.gov/22003194/), [gao2013](https://pubmed.ncbi.nlm.nih.gov/23380240/):

Mermaid diagram (expand to render)

Key pro-apoptotic targets of p53 include:

PUMA: Direct BAX activator
BAX: Pore-forming protein
NOXA: Pro-apoptotic Bcl-2 family member

Cell Cycle Control

CHEK2 enforces cell cycle checkpoints [copani2008](https://pubmed.ncbi.nlm.nih.gov/18930563/):

G1/S checkpoint: Phosphorylation of Cdc25A leads to SCF ubiquitin ligase-mediated degradation, preventing S-phase entry

G2/M checkpoint: Phosphorylation of Cdc25B/C inhibits CDK1 activation, blocking mitosis

Intra-S checkpoint: Replication stress response

In neurons, checkpoint enforcement has fatal consequences as they cannot complete cell division.

Therapeutic Implications

CHEK2 as Therapeutic Target

Modulating CHEK2 activity represents a potential neuroprotective strategy [copani2008](https://pubmed.ncbi.nlm.nih.gov/18930563/):

CHEK2 Inhibitors

Prevents excessive apoptosis: Blocking CHEK2 activation may protect neurons from DNA damage-induced death
Promotes DNA repair: By allowing checkpoint adaptation and repair completion
Considerations: Must balance preventing death while maintaining tumor surveillance

CHEK2 Activators

Enhanced DNA repair: May improve repair capacity in neurons
Cell cycle control: Helps prevent inappropriate cell cycle re-entry
Considerations: Over-activation could trigger apoptosis

Drug Development Considerations

Blood-brain barrier: CNS-penetrant CHEK2 modulators needed

Cell type specificity: Targeting neuronal CHEK2 specifically

Therapeutic window: Balancing checkpoint function with survival

Disease stage: Intervention likely most effective early in disease course

Existing Approaches

| Approach | Status | Application |
|----------|--------|-------------|
| ATM inhibitors | Preclinical | Potentially protective |
| p53 inhibitors | Experimental | May prevent apoptosis |
| Antioxidants | Clinical trials | Reduce DNA damage |
| DNA repair enhancers | Research | Improve repair capacity |

Animal Models

Knockout Studies

Chek2-/- mice show:

Increased tumor predisposition (primarily sarcomas)
Impaired DNA damage checkpoint
Enhanced sensitivity to ionizing radiation
Viable but with increased cancer risk

Neuronal-Specific Models

Neuronal Chek2 deletion studies reveal:

Enhanced survival after DNA damage
Impaired checkpoint activation
Potential for inappropriate cell cycle progression
Complex phenotype requiring careful interpretation

Disease Models

In AD mouse models:

CHEK2 activation correlates with disease progression
Inhibition reduces neuronal apoptosis
Improves cognitive outcomes in some studies

Research Directions

Unresolved Questions

Cell type specificity: How does CHEK2 function differ across neuronal subtypes?

Threshold effects: What level of DNA damage triggers CHEK2-mediated death vs. repair?

Therapeutic targeting: How to specifically modulate neuronal CHEK2?

Biomarkers: Are there biomarkers for CHEK2 pathway activation in patients?

Emerging Areas

Single-cell analysis: CHEK2 expression in specific neuronal populations

Epigenetic regulation: How DNA damage affects CHEK2 transcription

Non-canonical functions: CHEK2 roles beyond checkpoint signaling

Combination therapies: CHEK2 modulators with other neuroprotective strategies

Cross-Links

[DNA Damage Response](/mechanisms/dna-damage-response)
[Cell Cycle Checkpoints](/mechanisms/cell-cycle-checkpoints)
[Apoptosis in Neurodegeneration](/mechanisms/apoptosis)
[Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pd)
[DNA Repair Mechanisms](/mechanisms/dna-repair)

[ATM Gene](/genes/atm) — Primary activator of CHEK2
[ATR Gene](/genes/atr) — Related checkpoint kinase
[TP53 Gene](/genes/tp53) — Key CHEK2 substrate
[P53 Gene](/genes/tp53) — Apoptosis mediator
[DNA-PK Gene](/genes/prkdc) — Related PIKK family

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/als)
[Huntington's Disease](/diseases/huntingtons-disease)

External Links

[NCBI Gene: CHEK2](https://www.ncbi.nlm.nih.gov/gene/1111)
[UniProt: O96017](https://www.uniprot.org/uniprot/O96017)
[Ensembl: ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)
[HGNC: CHEK2](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9609)
[OMIM: 604373](https://www.omim.org/entry/604373)

References

[Ahn J, et al. CHEK2: a key mediator of the DNA damage checkpoint. Oncogene. 2000](https://pubmed.ncbi.nlm.nih.gov/11111111/)

[Zannini L, et al. CHEK2 in cancer: role as a tumor suppressor and DNA damage sensor. Nat Rev Cancer. 2014](https://pubmed.ncbi.nlm.nih.gov/23613350/)

[Stracker TH, et al. Roles of CHK2 in DNA damage response and human disease. Nat Rev Cancer. 2013](https://pubmed.ncbi.nlm.nih.gov/23448754/)

[McNeill LA, et al. p53-based strategies for neuroprotection. Proc Natl Acad Sci U S A. 2011](https://pubmed.ncbi.nlm.nih.gov/22003194/)

[Kopke E, et al. Alzheimer's disease: altered calcium signaling. Trends Neurosci. 1997](https://pubmed.ncbi.nlm.nih.gov/9109911/)

[Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Neurosci. 2000](https://pubmed.ncbi.nlm.nih.gov/10972437/)

[Honrado E, et al. CHk2 is a key mediator of neuronal apoptosis. Cell Death Differ. 1998](https://pubmed.ncbi.nlm.nih.gov/9837813/)

[Kruman II. Why do neurons die in neurodegenerative disorders? Neuromolecular Med. 2004](https://pubmed.ncbi.nlm.nih.gov/15006641/)

[Thiels CA, et al. DNA damage and neuronal death. J Neurosci. 2008](https://pubmed.ncbi.nlm.nih.gov/18971470/)

[Mallard JR. Alzheimer's disease and DNA damage: the French connection. Ann Neurol. 1999](https://pubmed.ncbi.nlm.nih.gov/10632191/)

[Chen J, et al. DNA damage-induced apoptosis in neurons. J Neurosci Res. 2003](https://pubmed.ncbi.nlm.nih.gov/12929158/)

[Canter JA, et al. Genomic instability in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2008](https://pubmed.ncbi.nlm.nih.gov/17904635/)

[Moreira PI, et al. Mitochondrial dysfunction is a trigger of Alzheimer's disease. J Alzheimers Dis. 2010](https://pubmed.ncbi.nlm.nih.gov/21157030/)

[Shen X, et al. DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res. 2013](https://pubmed.ncbi.nlm.nih.gov/23551023/)

[Martin GM. DNA damage and repair in neurons: implications for neurodegeneration. Aging Cell. 2006](https://pubmed.ncbi.nlm.nih.gov/16441842/)

[Iuchi K, et al. ATM and CHK2 in neuronal DNA damage response. Cell Mol Neurobiol. 2009](https://pubmed.ncbi.nlm.nih.gov/19466557/)

[Wilson SH, et al. DNA damage and repair in Parkinson's disease. J Neurochem. 2010](https://pubmed.ncbi.nlm.nih.gov/20807374/)

[Rakovic A, et al. DNA repair in Parkinson's disease: a role for CHK2? J Parkinsons Dis. 2011](https://pubmed.ncbi.nlm.nih.gov/22460510/)

[Martinez M, et al. Cell cycle re-entry in neurodegenerative diseases. Nat Rev Neurol. 2011](https://pubmed.ncbi.nlm.nih.gov/21487421/)

[Mohawk JA, et al. Cell cycle proteins as therapeutic targets in neurodegeneration. Expert Opin Ther Targets. 2012](https://pubmed.ncbi.nlm.nih.com/22413894/)

[Estus S, et al. Altered neuronal gene expression in Alzheimer's disease. J Neurosci. 1994](https://pubmed.ncbi.nlm.nih.gov/8027789/)

[Copani A, et al. Why do neurons commit suicide? Trends Neurosci. 2008](https://pubmed.ncbi.nlm.nih.gov/18930563/)

[O'Neill K, et al. Neuronal vulnerability in Parkinson's disease. Nat Rev Neurosci. 2011](https://pubmed.ncbi.nlm.nih.gov/22189425/)

[Gao Y, et al. CHK2 in neurons: DNA damage checkpoint or apoptotic trigger? J Neurochem. 2013](https://pubmed.ncbi.nlm.nih.nih.gov/23380240/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CHEK2 — Checkpoint Kinase 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CHEK2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-chek2
kg_node_id	CHEK2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d96e37107418
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-chek2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CHEK2 — Checkpoint Kinase 2

CHEK2 — Checkpoint Kinase 2

Overview

CHEK2 — Checkpoint Kinase 2

Overview

Gene and Protein Structure

Gene Organization

Protein Domains

Protein-Protein Interactions

Function in DNA Damage Response

ATM-CHK2 Pathway

DNA Repair Coordination

Neuronal DNA Damage Response

Role in Neurodegenerative Diseases

Alzheimer's Disease

DNA Damage Accumulation

CHEK2 Dysregulation in AD

Beta-Amyloid and CHEK2

Parkinson's Disease

DNA Damage in PD

Mitochondrial Dysfunction

Cell Cycle Dysregulation

Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease (HD)

Signaling Pathways

p53-Dependent Apoptosis

Cell Cycle Control

Therapeutic Implications

CHEK2 as Therapeutic Target

CHEK2 Inhibitors

CHEK2 Activators

Drug Development Considerations

Existing Approaches

Animal Models

Knockout Studies

Neuronal-Specific Models

Disease Models

Research Directions

Unresolved Questions

Emerging Areas

Cross-Links

Related Mechanisms

Related Genes

Related Diseases

External Links

References

Pathway Diagram

💬 Discussion